Submit Manuscript now
Impact Factor 2.6

Month: May 2021

Sorafenib-Induced Exosome Secretion Promotes Chemotherapy Resistance in Hepatoma Cell Line

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Abstract Hepatocellular Carcinoma (HCC) is a most common cause of cancer- related deaths globally. Traditional HCC treatments, including surgery, radiation therapy, and chemotherapy, could provide potential options; however, Sorafenib has been used for advanced HCC treatment. Unfortunately, most patients with advanced-stage HCC do not benefit from Sorafenib for its easy progression to resistance. Although …

Sorafenib-Induced Exosome Secretion Promotes Chemotherapy Resistance in Hepatoma Cell Line Read More »

The Prevalence of Depression and Its Association with Prior Opioid Use Among Patients in an Outpatient IBD Program

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Abstract 1.1. Background: Depression is a common comorbidity in chronic medical conditions including inflammatory bowel disease (IBD) and is a major determinant of health-related quality of life (HR-QOL). IBD patients often also experience chronic pain, and hence this population has significant opioid use. The aim of this study is to determine the prevalence of …

The Prevalence of Depression and Its Association with Prior Opioid Use Among Patients in an Outpatient IBD Program Read More »

Post Pandemic Challenges for Cancer Service Provision, The Need for A Fitting Strategy, A Standpoint from The UK

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Short Communication Soon after the 1st lockdown was imposed in the UK on March 27, 2020, all elective activity surgical and endoscopic stopped in James Cook University Hospital, Cleveland County in North of England. It was almost a standstill due to fear of the unknown and senior upper GI oncology surgeon, thinking how one …

Post Pandemic Challenges for Cancer Service Provision, The Need for A Fitting Strategy, A Standpoint from The UK Read More »

COVID-19 Presenting A Severe Acute Necrotizing Pancreatitis in Young Man Patient: A Case Report

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Abstract The novel coronavirus disease 2019 (COVID-19) is a highly infectious and rapidly spreading disease. There are limited published data on the epidemiology and outcomes of COVID-19 disease and pancreatitis. We think this is the first report describing MDCT findings of COVID-19 disease with severe acute necrotizing pancreatitis in young men.

Parietal Endometriosis; Cases Report and Review of Literature

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Abstract 1.1. Introduction: Parietal endometriosis is a rare condition that affects women of childbearing age, it represents a diagnostic challenge given the recurrent and atypical character. The different symptoms of each patient whose main symptom remains the catminaial pain and the palpation of a mass. The diagnosis is carried out primarily on the anatomopathological …

Parietal Endometriosis; Cases Report and Review of Literature Read More »

Pancreatic Neuroendocrine Tumors: The Experience of The “A” Visceral Surgery Department in The Light of the New Who 2017 Classification

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Abstract 1.1. Introduction: PNETs represent 1-5% of all NET and about 1% of pancreatic tumors. The object if of this study is to firstly introduce the update of the new WHO 2017 classification and to report epidemiological, clinical, paraclinical, therapeutic, anatomopathological and evolutive characteristics of cases of PNETs treated in our service.

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.